Nephros Inc
NASDAQ:NEPH
Nephros Inc
Total Current Assets
Nephros Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nephros Inc
NASDAQ:NEPH
|
Total Current Assets
$11.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
16%
|
|
|
Whirlpool Corp
NYSE:WHR
|
Total Current Assets
$4.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-3%
|
|
|
Hamilton Beach Brands Holding Co
NYSE:HBB
|
Total Current Assets
$304.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Cricut Inc
NASDAQ:CRCT
|
Total Current Assets
$499.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Vesync Co Ltd
HKEX:2148
|
Total Current Assets
$550.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sharkninja Inc
NYSE:SN
|
Total Current Assets
$3.6B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
See Also
What is Nephros Inc's Total Current Assets?
Total Current Assets
11.2m
USD
Based on the financial report for Dec 31, 2025, Nephros Inc's Total Current Assets amounts to 11.2m USD.
What is Nephros Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
16%
Over the last year, the Total Current Assets growth was 35%. The average annual Total Current Assets growth rates for Nephros Inc have been 11% over the past three years , -6% over the past five years , and 16% over the past ten years .
